Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16-Reference-Cited by-同舟云学术

Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16

Published:2020-03-03 Issue:3 Volume:15 Page:e0229787
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yang Justin C.^ORCID,Roman-Urrestarazu Andres,Brayne Carol

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction;A Kolodny;Annual review of public health,2015

2. Vital signs: trends in emergency department visits for suspected opioid overdoses—United States, July 2016–September 2017;AM Vivolo-Kantor;Morbidity and Mortality Weekly Report,2018

3. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015;RA Rudd;MMWR Morbidity and mortality weekly report,2016

4. Prescription opioid abuse: a literature review of the clinical and economic burden in the United States;R Meyer;Popul Health Manag,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous U.S.;Journal of Substance Use and Addiction Treatment;2024-01

2. Network Analysis of Medical Claims Data Suggests Network-Based, Regional Targeting and Intervention Delivery Strategies to Increase Access to Office Based Opioid Treatment (OBOT) for Opioid Use Disorder (OUD);INQUIRY: The Journal of Health Care Organization, Provision, and Financing;2024-01

3. Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims;Drug and Alcohol Dependence Reports;2023-12

4. Waiting times disparities for medication-assisted therapy among opioid use disorder treatment population in the United States;Journal of Addictive Diseases;2022-09-09

5. Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study;Journal of Substance Abuse Treatment;2022-08